Abstract

Pharmaceutical Patent AnalystVol. 9, No. 5 Patent SpotlightThree drugs facing key patent expirations and potential generic entry from September to October 2020Yali FriedmanYali Friedman*Author for correspondence: E-mail Address: yali@DrugPatentWatch.comDrugPatentWatchSearch for more papers by this authorPublished Online:22 Oct 2020https://doi.org/10.4155/ppa-2020-0029AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View article"Three drugs facing key patent expirations and potential generic entry from September to October 2020." Pharmaceutical Patent Analyst, 9(5), pp. 147–148Keywords: intellectual propertyloss of exclusivitypatents

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call